Inverness Counsel LLC Bristol Myers Squibb CO Transaction History

Inverness Counsel LLC

$1.8 Billion
Q3 2022

A detailed history of Inverness Counsel LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Inverness Counsel LLC holds 9,579 shares of BMY stock, worth $446,860. This represents 0.04% of its overall portfolio holdings.

Number of Shares

9,579

Previous 8,862 8.09%

Holding current value

$446,860

Previous $682,000 0.15%

% of portfolio

0.04%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$0.13 - $76.84 $93 - $55,094	717 Added 8.09%	9,579 $681,000
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $6,535 - $7,198	-90 Reduced 1.01%	8,862 $682,000
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $4,426 - $5,307	72 Added 0.81%	8,952 $654,000
Q3 2021 Nov 02, 2021	SELL	$59.17 - $69.31 $22,188 - $25,991	-375 Reduced 4.05%	8,880 $525,000
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $20,120 - $21,911	-325 Reduced 3.39%	9,255 $618,000
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $38,571 - $43,381	650 Added 7.28%	9,580 $605,000
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $55,419 - $61,412	-965 Reduced 9.75%	8,930 $538,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $131,239 - $153,431	-2,394 Reduced 19.48%	9,895 $582,000
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $105,281 - $152,998	2,269 Added 22.64%	12,289 $685,000
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $15,993 - $20,861	325 Added 3.35%	10,020 $643,000
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $6,415 - $7,606	-150 Reduced 1.52%	9,695 $492,000
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $11,601 - $12,828	-260 Reduced 2.57%	9,845 $446,000
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $110,544 - $131,810	-2,450 Reduced 19.51%	10,105 $482,000
Q4 2018 Jan 29, 2019	SELL	$48.76 - $63.23 $37,057 - $48,054	-760 Reduced 5.71%	12,555 $652,000
Q3 2018 Oct 30, 2018	BUY	$55.19 - $62.25 $25,387 - $28,635	460 Added 3.58%	13,315 $827,000
Q2 2018 Aug 02, 2018	SELL	$50.53 - $62.98 $28,751 - $35,835	-569 Reduced 4.24%	12,855 $711,000
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $147,343 - $169,621	2,459 Added 22.43%	13,424 $849,000
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $47,952 - $52,279	-800 Reduced 6.8%	10,965 $672,000
Q3 2017 Oct 17, 2017	BUY	$55.23 - $63.74 $649,780 - $749,901	11,765	11,765 $750,000

Others Institutions Holding BMY

# of Institutions

2,811

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.2B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.

Account

Inverness Counsel LLC Bristol Myers Squibb CO Transaction History